Baicalin attenuates bleomycin-induced pulmonary fibrosis via adenosine A2a receptor related TGF-β1-induced ERK1/2 signaling pathway

BackgroundBaicalin has been reported to have anti-fibrosis effect; however, its mechanism still remains to be elucidated. Adenosine A2a receptor (A2aR) is a novel inflammation regulator, and transforming growth factor-β1 (TGF-β1)-induced extracellular signal regulated kinase1/2 (ERK1/2) signaling pathway plays an important role in idiopathic pulmonary fibrosis (IPF). This study was to explore the relationship of A2aR and TGF-β1-induced ERK1/2 in bleomycin (BLM)-induced pulmonary fibrosis in mice, and to investigate whether A2aR mediate the anti-fibrosis effect of Baicalin on BLM-induced pulmonary fibrosis.MethodsThe A2aR−/− and A2aR+/+ mice were respectively divided into three groups: control group, model group, baicalin group. Pulmonary fibrosis was induced in mice of model groups by intratracheal instillation of bleomycin, and baicalin was administered in mice of baicalin groups daily for 28 days. Histopathological and ultrastructural changes of lung tissues were evaluated. Lung coefficient and the levels of hydroxyproline (HYP) in lung tissues were measured at the same time. The levels of serum TGF-β1 were measured by ELISA. The expression of TGF-β1, ERK1/2, p-ERK1/2 and A2aR were detected by western blot and immunohistochemical staining techniques.ResultsSevere lung fibrosis was observed in the bleomycin-treated mice on day 28. The histopathological findings and collagen content of lung tissues were much severer/higher in A2aR−/− mice than in A2aR+/+ mice. We also showed that TGF-β1 and p-ERK1/2 were upregulated in bleomycin-treated mice and expressed higher in A2aR−/− mice compared to A2aR+/+ mice. Besides, bleomycin-treated A2aR+/+ mice had increased A2aR level in lungs. However, long-term treatment with baicalin in A2aR−/− and A2aR+/+ mice significantly ameliorated the histopathological changes in lungs. Moreover, Increased TGF-β1 and p-ERK1/2 expressions in bleomycin-treated A2aR−/− and A2aR+/+ mice were obviously diminished by baicalin. The baicalin-treated A2aR−/− mice had severer lung fibrosis and higher expressions of TGF-β1 and p-ERK1/2 than A2aR+/+ mice. Baicalin has also upregulated the expression of A2aR in A2aR+/+ mice.ConclusionsGenetic inactivation of A2aR exacerbated the pathological processes of bleomycin-induced pulmonary fibrosis. Together, baicalin could inhibit BLM-induced pulmonary fibrosis by upregulating A2aR, suggesting A2aR as a therapeutic target of baicalin for the treatment of pulmonary fibrosis.

[1]  Yu-yan Hu,et al.  [Baicalin prevents the up-regulation of connective tissue growth factor in fibrotic lungs of rats]. , 2010, Sheng li xue bao : [Acta physiologica Sinica].

[2]  M. Blackburn,et al.  Adenosine receptors and inflammation. , 2009, Handbook of experimental pharmacology.

[3]  B. Fanburg,et al.  Transforming Growth Factor-β1-induced Activation of the ERK Pathway/Activator Protein-1 in Human Lung Fibroblasts Requires the Autocrine Induction of Basic Fibroblast Growth Factor , 2000 .

[4]  B. Fanburg,et al.  Transforming growth factor-beta 1-induced activation of the ERK pathway/activator protein-1 in human lung fibroblasts requires the autocrine induction of basic fibroblast growth factor. , 2000, The Journal of biological chemistry.

[5]  I. Noth,et al.  Oral immunotherapy with type V collagen in idiopathic pulmonary fibrosis , 2015, European Respiratory Journal.

[6]  Hui-Bie F. Xu,et al.  Protective effects of flavonoids in the roots of Scutellaria baicalensis Georgi against hydrogen peroxide-induced oxidative stress in HS-SY5Y cells. , 2001, Pharmacological research.

[7]  Xiao-dong Peng,et al.  Correlation between anti-fibrotic effect of baicalin and serum cytokines in rat hepatic fibrosis. , 2009, World journal of gastroenterology.

[8]  Pál Pacher,et al.  Adenosine receptors: therapeutic aspects for inflammatory and immune diseases , 2006, Nature Reviews Drug Discovery.

[9]  E. Choi,et al.  Serial Micro-CT Assessment of the Therapeutic Effects of Rosiglitazone in a Bleomycin-Induced Lung Fibrosis Mouse Model , 2014, Korean journal of radiology.

[10]  Khusru Asadullah,et al.  Mechanisms involved in the side effects of glucocorticoids. , 2002, Pharmacology & therapeutics.

[11]  S. Rosselot.  Idiopathic pulmonary fibrosis. , 2014, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[12]  Q. Xie,et al.  TGF-beta1 induces alveolar epithelial to mesenchymal transition in vitro. , 2004, Life sciences.

[13]  Noboru Fukuda,et al.  Transforming growth factor-beta expression in cardiovascular organs in stroke-prone spontaneously hypertensive rats with the development of hypertension. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[14]  T. Oury,et al.  Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. , 2005, American journal of respiratory and critical care medicine.

[15]  K. Flaherty,et al.  Corticosteroids in idiopathic pulmonary fibrosis , 2001, Current opinion in pulmonary medicine.

[16]  Ling-Hao Li,et al.  Baicalin induces apoptosis in hepatic cancer cells in vitro and suppresses tumor growth in vivo. , 2015, International journal of clinical and experimental medicine.

[17]  Liangxing Wang,et al.  Effects of baicalin on collagen Ι and collagen ΙΙΙ expression in pulmonary arteries of rats with hypoxic pulmonary hypertension , 2015, International journal of molecular medicine.

[18]  L. Belardinelli,et al.  Alterations in Adenosine Metabolism and Signaling in Patients with Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis , 2010, PloS one.

[19]  I. Irminger-Finger,et al.  BARD1 mediates TGF-β signaling in pulmonary fibrosis , 2015, Respiratory Research.

[20]  K. Antoniou,et al.  Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future , 2013, European Respiratory Review.

[21]  Stephanie R. Kuzenko,et al.  The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats. , 2012, American Journal of Physiology - Lung cellular and Molecular Physiology.

[22]  A. IJzerman,et al.  Internalization and desensitization of adenosine receptors , 2007, Purinergic Signalling.

[23]  V. Cottin.  Changing the idiopathic pulmonary fibrosis treatment approach and improving patient outcomes , 2012, European Respiratory Review.

[24]  Samy Lamouille,et al.  TGF-β-induced epithelial to mesenchymal transition , 2009, Cell Research.

[25]  S. Peng,et al.  ERK in Learning and Memory: A Review of Recent Research , 2010, International journal of molecular sciences.

[26]  W. Xu,et al.  A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin. , 2011, Die Pharmazie.

[27]  D. Heinegård,et al.  Extracellular matrix alterations and acute inflammation; developing in parallel during early induction of pulmonary fibrosis , 2012, Laboratory Investigation.

[28]  Q. Xie,et al.  RETRACTED: TGF-β1 induces alveolar epithelial to mesenchymal transition in vitro , 2004 .

[29]  E. Pajtasz-Piasecka,et al.  Baicalin from the extract of Scutellaria baicalensis affects the innate immunity and apoptosis in leukocytes of children with acute lymphocytic leukemia. , 2014, International immunopharmacology.

[30]  B. Willis,et al.  Epithelial origin of myofibroblasts during fibrosis in the lung. , 2006, Proceedings of the American Thoracic Society.

[31]  U. Hempel,et al.  Transforming growth factor-beta1-induced activation of the Raf-MEK-MAPK signaling pathway in rat lung fibroblasts via a PKC-dependent mechanism. , 1998, Biochemical and biophysical research communications.

[32]  S. Chao,et al.  Therapeutic effects of baicalin on monocrotaline-induced pulmonary arterial hypertension by inhibiting inflammatory response. , 2015, International immunopharmacology.

[33]  H. van Belle,et al.  Formation and release of purine catabolites during hypoperfusion, anoxia, and ischemia. , 1987, The American journal of physiology.

[34]  E. Barreiro,et al.  Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline‐induced pulmonary hypertension in rats , 2013, British journal of pharmacology.

[35]  B. Cronstein,et al.  Adenosine: an endogenous regulator of innate immunity. , 2004, Trends in immunology.

[36]  Hui Wang,et al.  Effect of Feitai on bleomycin-induced pulmonary fibrosis in rats. , 2005, Journal of ethnopharmacology.

[37]  M. Horton,et al.  The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. , 2009, American journal of respiratory cell and molecular biology.

[38]  F. Martinez,et al.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. , 2004, Drugs.

[39]  B. Willis,et al.  TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[40]  W. Coward,et al.  The pathogenesis of idiopathic pulmonary fibrosis , 2010, Therapeutic advances in respiratory disease.

[41]  B. Willis,et al.  TGF-β-induced EMT: mechanisms and implications for fibrotic lung disease , 2007 .

[42]  Liang-Yi Si,et al.  Adenosine A2A Receptor: A Target for Regulating Renal Interstitial Fibrosis in Obstructive Nephropathy , 2013, PloS one.

[43]  H. Hao,et al.  Baicalin suppresses expression of TLR2/4 and NF-κB in chlamydia trachomatis–infected mice , 2012, Immunopharmacology and immunotoxicology.

[44]  Clay C C Wang,et al.  Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator‐activated receptor γ in hepatic stellate cells for their antifibrotic effect , 2012, Hepatology.

[45]  C. C. Lin,et al.  The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. , 1996, The American journal of Chinese medicine.

[46]  M. Gyetko,et al.  Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. , 2009, Current medicinal chemistry.

[47]  D. Warburton,et al.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? , 2008, The international journal of biochemistry & cell biology.

[48]  D. Sheppard,et al.  Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix , 2006, Proceedings of the National Academy of Sciences.